Improving sample size recalculation in adaptive clinical trials by resampling
Open Access
- 1 April 2021
- journal article
- research article
- Published by Wiley in Pharmaceutical Statistics
- Vol. 20 (6) , 1035-1050
Abstract
Sample size calculations in clinical trials need to be based on profound parameter assumptions. Wrong parameter choices may lead to too small or too high sample sizes and can have severe ethical and economical consequences. Adaptive group sequential study designs are one solution to deal with planning uncertainties. Here, the sample size can be updated during an ongoing trial based on the observed interim effect. However, the observed interim effect is a random variable and thus does not necessarily correspond to the true effect. One way of dealing with the uncertainty related to this random variable is to include resampling elements in the recalculation strategy. In this paper, we focus on clinical trials with a normally distributed endpoint. We consider resampling of the observed interim test statistic and apply this principle to several established sample size recalculation approaches. The resulting recalculation rules are smoother than the original ones and thus the variability in sample size is lower. In particular, we found that some resampling approaches mimic a group sequential design. In general, incorporating resampling of the interim test statistic in existing sample size recalculation rules results in a substantial performance improvement with respect to a recently published conditional performance score.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (KI 708/4‐1, RA 2347/4‐1)
This publication has 25 references indexed in Scilit:
- Sample size re-estimation in a breast cancer trialClinical Trials, 2010
- Efficient group sequential designs when there are several effect sizes under considerationStatistics in Medicine, 2005
- Bayesian predictive approach to interim monitoring in clinical trialsStatistics in Medicine, 2005
- On the inefficiency of the adaptive design for monitoring clinical trialsBiometrika, 2003
- Issues in designing flexible trialsStatistics in Medicine, 2003
- Sample size re‐estimation – journey for a decadeStatistics in Medicine, 2001
- Modification of Sample Size in Group Sequential Clinical TrialsBiometrics, 1999
- Evaluation of Experiments with Adaptive Interim Analyses1994
- A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinionStatistics in Medicine, 1986
- On the Language of PainAnesthesiology, 1971